Venus Remedies for the first time has launched a research-based product, Trois, in the Indian market. This patent protected topical nano-emulsion has been developed by using the integrated natural medicine approach to relieve from all kind of arthritic pain.
Talking about the product, Dr Manu Chaudhary, Joint Managing Director and Director-Research, Venus Remedies said, “The problem of arthritis is a constantly growing epidemic in India. As per the latest reports, almost 15 per cent of the Indian population is suffering with this crippling disease. We felt the pressing need to develop an alternative solution for rheumatic disorders and related infections, thus have come up for the first time with a topical nano emulsion Trios to relieve the arthritic pain.”
According to the company release, prevalent treatment of rheumatoid diseases includes drugs such as non-steroidal, anti-inflammatory drugs (NSAIDS), corticosteroids, slow acting anti-rheumatic drugs (SAARDS) or disease modifying (DM) drugs include penicillin amine like drugs such as cyclophosphamide, methotrexate, gold salts, azothioprine, levamisole and the like. All these drugs have severe side effects and most of them are cytotoxic.
Dheeraj Aggarwal, CFO, Venus Remedies, “With the kind of response we are getting for this revolutionary nano-tech emulsion in pain management as topical pain killer in arthritis, we are hopeful of capturing a significant share of the rheumatoid arthritis drug market in India, which is speculated to grow up to $672 million in 2013.”
Trois has been awarded gold medal in 2011, under India Innovation Growth Programme, organised by FICCI, Lockheed Martin and IC2 Institute, Texas. He further added, “We have already filed patents for Trois in the major markets across the globe and based on the regulatory approvals, we are soon going to launch our products in the international markets as well.”
Trois is indicated for the treatment of pain and inflammation as associated with osteoarthritis, rheumatoid arthritis, juvenile idiopathic arthritis, gouty arthritis, ankylosing spondylitis, psoriatic arthritis, backache, sprain and fibromyalgia.
EP News Bureau
